| ALI | Acute lung injury |
| AMs | Alveolar macrophages |
| AP-1 | Activator protein-1 |
| ARDS | Acute respiratory distress syndrome |
| ATII | Alveolar cell type II |
| BAL | Bronchoalveolar lavage |
| cAMP | Cyclic adenosine monophosphate |
| CAP | Community-acquired pneumonia |
| cGMP | Cyclic guanosine monophosphate |
| CREB | cAMP response element-binding protein |
| CRP | C-reactive protein |
| DAMPs | Damage-associated molecular pattern molecules |
| ERK | Extracellular signal-regulated kinases |
| FQs | Fluoroquinolones |
| GM-CSF | Granulocyte–macrophage colony-stimulating factor |
| hPBL | Human peripheral blood lymphocytes |
| IFN | Interferon |
| IL | Interleukin |
| iNOS | Inducible NO synthase |
| IκB | Inhibitory κappa B |
| JNK | c-Jun N-terminal kinases |
| KC | Keratinocytes-derived chemokine |
| LPS | Lipopolysaccharide |
| MAMPs | Microbe-associated molecular patterns |
| MAPK | Mitogen-activated protein kinase |
| MCP-1 | Monocyte chemotactic protein |
| MIP-1α | Macrophage inflammatory protein 1α |
| Mpro | Main protease |
| NET | Neutrophil extracellular trap |
| NF-κB | Nuclear factor κappa-B |
| NO | Nitric oxide |
| PAMPs | Pathogen-associated molecular patterns |
| PBMCs | Peripheral blood mononuclear cells |
| PDEs | Phosphodiesterases |
| PKA | Protein kinase A |
| PRRs | Pattern recognition receptors |
| RBCs | Red blood cells |
| RCT | Randomised controlled trial |
| ROS | Reactive oxygen species |
| SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 |
| TAK1 | Transforming growth factor-activated kinase 1 |
| TLR | Toll-like receptor |
| TNF | Tumour necrosis factor |